Home
Genomic Valley Biotech Ltd PE Ratio

Genomic Valley Biotech Ltd
NSE: GENOMICVALLEY
PE
Key Highlights
- The P/E Ratio of Genomic Valley Biotech Ltd is 50.3 as of 22 Apr 9.00 AM .
- The P/E Ratio of Genomic Valley Biotech Ltd changed from 694.2 on March 2024 to 694.2 on March 2024 . This represents a CAGR of 0.00% over 1 years.
- The Latest Trading Price of Genomic Valley Biotech Ltd is ₹ 63.44 as of 21 Apr 15:30 .
- The PE Ratio of Miscellaneous Industry has changed from -66.6 to 234.8 in 5 years. This represents a CAGR of NaN%.
- The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 26.9. The PE Ratio of Miscellaneous industry is 234.8. The PE Ratio of Retail industry is 159.2. The PE Ratio of Textiles industry is 37.1 in 2024.
Historical P/E Ratio of Genomic Valley Biotech Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Genomic Valley Biotech Ltd
Company Fundamentals for Genomic Valley Biotech Ltd

Genomic Valley Biotech Ltd
NSE: GENOMICVALLEY
Share Price
Market Price of Genomic Valley Biotech Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Apr 2025 | 63.44 |
17 Apr 2025 | 63.13 |
16 Apr 2025 | 62.1 |
15 Apr 2025 | 62.07 |
11 Apr 2025 | 60.3 |
09 Apr 2025 | 58 |
08 Apr 2025 | 55.37 |
07 Apr 2025 | 52.75 |
04 Apr 2025 | 50.24 |
03 Apr 2025 | 52.25 |
BlinkX Score for Genomic Valley Biotech Ltd
Asset Value vs Market Value of Genomic Valley Biotech Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/E Ratio
Company | Market Cap | PE Ratio |
---|
Genomic Valley Biotech Ltd | 19.38 | 50.35 |
GMR Airports Ltd | 91610 | 0.0 |
OneSource Specialty Pharma Ltd | 17315 | 0.0 |
International Gemmological Institute (India) Ltd | 15942 | 37.3 |
Embassy Developments Ltd | 13106 | 0.0 |
Rites Ltd | 11674 | 30.9 |
Company | |
---|---|
Genomic Valley Biotech Ltd | 19.38 |
GMR Airports Ltd | 91610 |
OneSource Specialty Pharma Ltd | 17315 |
International Gemmological Institute (India) Ltd | 15942 |
Embassy Developments Ltd | 13106 |
Rites Ltd | 11674 |
PE Ratio of Genomic Valley Biotech Ltd Explained
₹19.38
Market cap
₹0
Earnings
50.3X
PE Ratio
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.
P/E Ratio Formula
P/E ratio = (CMP of share/ Earning per share)
Types of Price to Earning Ratio
1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
PE Ratio of Miscellaneous Industry over time
PE Ratio of Top Sectors
Historical Market Cap of Genomic Valley Biotech Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Genomic Valley Biotech Ltd
Historical Revenue, EBITDA and Net Profit of Genomic Valley Biotech Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Genomic Valley Biotech Ltd
Revenue
EBITDA
Net Profit
Historical Dividend Payout of Genomic Valley Biotech Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payout of Genomic Valley Biotech Ltd
About Genomic Valley Biotech Ltd
- Incorporated in May 1994, Genomic Valley Biotech Limited is formed with the objective of conducting research in the field of Biotechnology (Plant & Animal) and also to undertake commercial production of Plant Tissue Cultured Plants of different species to feed the genetically improved plant market nationally as well as internationally.
- The Company is extensively involved in commercial greenhouse / poly house cultivation of crops.
- Presently, it is engaged in high-tech cultivation through environmental controlled Poly Houses,NFT & DFT etc,manufacturing of Tissue Cultured Improved variety of plants and organic farming using Bio-Fertilizer.
- Also it is involved in commercial Horticulture activities with Aloe vera, Tomato, Bitter Gourd, Bottle Gourd, Brinjal, Broccoli, Cabbage, Capsicum, Carrot, Cauliflower, Cucumber, Green Chillies, Onion, Radish, Ridge/Sponge Gourd, Leafy Vegetables, Pumpkin, Banana, Guava, Papaya, and Strawberry.
Genomic Valley Biotech Ltd News Hub
Genomic Valley Biotech standalone net profit rises 650.00% in the September 2024 quarter
Net profit of Genomic Valley Biotech rose 650.00% to Rs 0.15 crore in the quarter ended September 20
Read more
08 Oct 24
Genomic Valley Biotech to discuss results
Genomic Valley Biotech will hold a meeting of the Board of Directors of the Company on 7 October 202
Read more
03 Oct 24
Genomic Valley Biotech to convene board meeting
Genomic Valley Biotech will hold a meeting of the Board of Directors of the Company on 14 February 2
Read more
11 Feb 25
Genomic Valley Biotech schedules AGM
Genomic Valley Biotech announced that the Annual General Meeting(AGM) of the company will be held on
Read more
07 Dec 24